We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+11.94%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.09B
AUM Growth
+$126M
Cap. Flow
-$32.2M
Cap. Flow %
-2.96%
Top 10 Hldgs %
17.76%
Holding
250
New
59
Increased
62
Reduced
48
Closed
32

Sector Composition

Rank Sector Weight
1 Industrials 21.1%
2 Technology 20.43%
3 Healthcare 16.49%
4 Financials 11.58%
5 Consumer Discretionary 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBB icon
101
iShares Biotechnology ETF
IBB
$9.71B
$3.78M 0.35%
+25,939
New +$3.75M
TPG icon
102
TPG
TPG
$7.86B
$3.74M 0.34%
+64,986
New +$3.2M
RXST icon
103
RxSight
RXST
$260M
$3.67M 0.34%
74,347
-69,424
-48% -$3.56M
GOOG icon
104
Alphabet (Google) Class C
GOOG
$4.32T
$3.65M 0.33%
21,818
+594
+3% +$101K
VRT icon
105
Vertiv
VRT
$105B
$3.61M 0.33%
36,259
+16,950
+88% +$1.41M
DKS icon
106
Dick's Sporting Goods
DKS
$18.7B
$3.57M 0.33%
+17,125
New +$3.66M
LUV icon
107
Southwest Airlines
LUV
$23B
$3.56M 0.33%
120,089
+102,474
+582% +$2.84M
RKT icon
108
Rocket Companies
RKT
$38.9B
$3.54M 0.32%
+184,406
New +$3.24M
QQQ icon
109
Invesco QQQ Trust
QQQ
$481B
$3.48M 0.32%
+7,123
New +$3.37M
KRYS icon
110
Krystal Biotech
KRYS
$9.66B
$3.42M 0.31%
18,807
+1,480
+9% +$285K
VERA icon
111
Vera Therapeutics
VERA
$2.36B
$3.16M 0.29%
71,559
+12,430
+21% +$472K
HROW icon
112
Harrow
HROW
$1.51B
$3.12M 0.29%
+69,477
New +$2.35M
ACLX
113
DELISTED
Arcellx
ACLX
$3.06M 0.28%
+36,586
New +$2.44M
KVYO icon
114
Klaviyo
KVYO
$4.73B
$3.04M 0.28%
+86,046
New +$2.49M
BCAX
115
Bicara Therapeutics
BCAX
$1.84B
$2.99M 0.27%
+117,523
New +$3M
WGS icon
116
GeneDx Holdings
WGS
$2.3B
$2.94M 0.27%
+69,337
New +$2.34M
SPRY icon
117
ARS Pharmaceuticals
SPRY
$612M
$2.93M 0.27%
+201,771
New +$2.4M
RVMD icon
118
Revolution Medicines
RVMD
$44B
$2.83M 0.26%
62,300
-95,832
-61% -$4.17M
ASTH icon
119
Astrana Health
ASTH
$1.77B
$2.79M 0.26%
+48,131
New +$2.36M
AXGN icon
120
Axogen
AXGN
$2.5B
$2.76M 0.25%
+197,135
New +$2.18M
GKOS icon
121
Glaukos
GKOS
$10.6B
$2.7M 0.25%
+20,724
New +$2.58M
RLAY icon
122
Relay Therapeutics
RLAY
$4.33B
$2.66M 0.24%
+376,014
New +$2.81M
UBER icon
123
Uber
UBER
$153B
$2.66M 0.24%
35,332
-34,600
-49% -$2.44M
ARCB icon
124
ArcBest
ARCB
$3.08B
$2.64M 0.24%
24,352
-37,755
-61% -$4.14M
NVMI
125
Nova
NVMI
$12.5B
$2.61M 0.24%
+12,523
New +$2.67M

Similar funds

Nicholas Investment Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Nicholas Investment Partners held 250 positions worth $1.09B, up 13% from $964M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners's Q3 2024 filing shows 59 new, 62 increased, 48 reduced and 32 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 15,515 shares worth $8.9M. The largest sale was Monolithic Power Systems, an estimated $15.8M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.

  • Nicholas Investment Partners's largest Q3 2024 buy was State Street SPDR S&P 500 ETF Trust: 15,515 shares worth $8.9M.
  • Nicholas Investment Partners added most to Western Alliance Bancorporation in Q3 2024, an estimated $4.67M increase.
  • Nicholas Investment Partners's biggest Q3 2024 reduction was Monolithic Power Systems, cutting an estimated $15.8M.
  • Nicholas Investment Partners fully exited Crane NXT in Q3 2024, selling an estimated $13.8M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.09B portfolio in Q3 2024.
  • Nicholas Investment Partners opened 59 new positions and closed 32 in Q3 2024.
  • Nicholas Investment Partners's portfolio value rose 13% quarter-over-quarter to $1.09B.

Based on Nicholas Investment Partners's 13F filing for Q3 2024, filed 12 Nov 2024.